Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...

A father has lost six stone in 11 months by taking Mounjaro, yet he face accusations on social media, saying that he is a 'lazy cheat' and that he is 'taking the easy way out'.

The launch of GLP-1 weight loss drugs in India is gaining popularity. Harvard researchers share a comprehensive guidance for ...

In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

GLP-1 drugs may be hailed as a medical breakthrough in obesity care, but Indian experts warn they are no cosmetic quick-fix.

For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...

LLY has slid 15.7% over the past year, but surging demand for Mounjaro and Zepbound could revive the stock's momentum.

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising ...

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...

Some of these symptoms will not go away, but luckily, you won’t be taking the GLP-1 forever,” Dr. Elizabeth Walton said.